Actions of Aihua Pan continue to harm the Company’s shareholders and customers BEIJING, May 8, 2018 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac ” Continue Reading
admin
Editorial administrator
Ascensia Diabetes Care Launches Smarter Version of CONTOUR®DIABETES App with New Features to Support Self-Management
BASEL, Switzerland, May 9, 2018 /PRNewswire/ — Ascensia Diabetes Care today announced that it has now launched its upgraded version of the CONTOUR®DIABETES app in Continue Reading
NeuClone Announces Preclinical Results for Stelara® (ustekinumab) Biosimilar Candidate
SYDNEY, May 10, 2018 /PRNewswire/ — Biopharmaceutical company NeuClone has announced positive preclinical results of its biosimilar to Johnson & Johnson’s Stelara®, including 3-dimensional (3-D) Continue Reading
Sinovac Files 2017 Annual Report on Form 20-F and Reports Unaudited Second Half, Audited Full Year 2017 Financial Results
BEIJING, May 11, 2018 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today Continue Reading
AGC Biologics enters into Commercial Supply Agreement with MacroGenics
BOTHELL, Washington, May 10, 2018 /PRNewswire/ — AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that in late 2017 Continue Reading
VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits
ISNES, Belgium, May 9, 2018 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced that it has entered into a Global Sales and Distribution Agreement with Continue Reading
Kaneka Corporation Will Appeal the District Court for the Central District of California Decision in the U.S. Patent Infringement Lawsuit Relating to Oxidized Coenzyme Q10
TOKYO, May 10, 2018 /PRNewswire/ — Kaneka Corporation has been in dispute with Xiamen Kingdomway Group Company since March 2011, when Kaneka instituted a patent Continue Reading
CStone Raises $260 million in Series B Financing to Advance Novel Cancer Therapies
SUZHOU, China, May 9, 2018 /PRNewswire/ — CStone Pharmaceuticals (“CStone”) announced today the successful completion of a $260 million (about RMB1.65 billion) financing, the largest Continue Reading
CEDRUS Investments WILL launch a new office in Shenzhen
Expanding its Footprint in the Greater China Region and Capitalizing on Life Sciences Innovation and Hi-tech Investment Opportunities HONG KONG, May 9, 2018 /PRNewswire/ — Cedrus Continue Reading
Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future
RARITAN, New Jersey and SINGAPORE, May 8, 2018 /PRNewswire/ — Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, will host the Ortho Continue Reading